Vitalgenics Inc has developed Excindogen to treat in cure pancreatic cancer. Excindogen is a small molecule GPCR inhibitor that prevents DNA damage and mutations. If you do not have DNA damage or mutations you do not have a cancer cell or tumor. Think about that. Excindogen is non-toxic with no major side effects. No hair loss, no compromised immune system no infections from using Excindogen. we are planning a phase1 / phase 2 clinical trial in advanced stage pancreatic cancer and are seeking investors.